from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3872/PE35

LFCtreatmentdescriptionclass of inhibitor

1.947

Amikacinug/mL Amikacintranslation

2.866

Cap5-10ug/mL Capreomycintranslation

1.755

Rox10-50 ug/mL Roxithromycintranslation

0.648

SM2-5 ug/mL Streptomycintranslation

3.086

Tet5-10 ug/mL Tetracyclinetranslation

-0.729

Rif0.2-5ug/mL Rifampicintranscription

-0.768

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.132

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.818

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.371

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.101

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.552

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.161

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.519

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.288

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.509

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.322

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.200

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.655

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.206

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.647

KCN5-20 ug/mL Potassium cyaniderespiration

-0.335

NaN30.2-2 mM Sodium aziderespiration

0.565

Nigericin50 uM Nigericinrespiration

-0.406

TRC10-150 ug/mL Triclosanrespiration

1.756

TRZ10-25 ug/mL Thioridazinerespiration

2.857

Valinomycin0.5-10 uM Valinomycinrespiration

-0.223

ZnSO42 mM ZnSO4respiration

-0.711

menadione6-10 ug/mL Menadionerespiration

-0.530

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.354

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.462

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.727

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.025

NRP_1Non-replicating persistence stage 1dosRassociated

0.650

Amp0.2mg/mL AmpicillincellWall

-0.139

Cephalexin20-100 ug/mL CephalexincellWall

0.605

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.130

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.122

EMB10-20 ug/mL EthambutolcellWall

0.669

Eta12-40 ug/mL EthionamidecellWall

0.974

INH0.2-0.4 ug/mL IsoniazidcellWall

0.081

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.580

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.043

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.345

BZA0.12 mg/mL BenzamidearomaticAmides

0.256

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.179

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.015

H2O24 mM hydrogen peroxideDNAdamaging

-0.544

Levo10 ug/mL LevofloxacinDNAdamaging

0.019

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.758

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.752

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.102

UVUV-irradiationDNAdamaging

-0.648

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.643

Antimycin12.5-50 ug/mL Antimycin A?

-1.183

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.168

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.540

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.304

PA8240.2-2 ug/mL PA-824?

1.085

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.191

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.250

Verapamil50 uM Verapamil?

-1.657

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.294

methoxatin10-20 ug/mL Methoxatin?